Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA)

Hal Broxmeyer, Peter Ralph, Valerie B. Margolis, Ilona Nakoinz, Paul Meyers, Neena Kapoor, Malcolm A S Moore

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Cells in the bone marrow and blood of patients with acute and chronic myeloid and lymphoid leukemia which produce leukemia inhibitory activity (LIA) specific for normal granulocyte-macrophage progenitor cells (CFU-c) have been characterized as belonging to the third population of lymphoid-like cells which are neither T nor B but which have Fe receptors. The cells are non-adherent, non-phagocytic, of low density (3), slowly sedimenting (2-6 mm/h) and present in the sheep red blood cell rosetting populations which are E-, EAC-, Ig-, EA+, and are Ia- as determined by a complement cytotoxicity test using rabbit anti-human Ia-like antibody. The LIA-producing cell has been further characterized by its response to certain agents with known immunoregulatory activity. Bacterial lipopolysaccharide, tuberculin purified protein derivative, Bacillus Calmette-Guérin, dextran sulphate and pokeweed mitogen suppressed the production of LIA. Total suppression of LIA production by LPS required the constant presence of this agent; but hydrocortisone and dexamethasone abrogated LPS suppression of LIA production. LIA could not be found in normal human adult bone marrow and blood cells or fetal bone marrow, spleen, or liver cells. Further evidence for the specificity of LIA action was obtained since LIA did not inhibit erythropoietin dependent human erythroid progenitor cell (BFU-e, CFU-e) proliferation.

Original languageEnglish (US)
Pages (from-to)193-203
Number of pages11
JournalLeukemia Research
Volume3
Issue number4
DOIs
StatePublished - 1979
Externally publishedYes

Fingerprint

Bone Marrow Cells
Blood Cells
Leukemia
Pokeweed Mitogens
Dextran Sulfate
Granulocyte-Macrophage Progenitor Cells
Erythroid Precursor Cells
Tuberculin
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Erythropoietin
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
Bacillus
Dexamethasone
Population
Lipopolysaccharides
Hydrocortisone
Sheep
Spleen
Erythrocytes

Keywords

  • Cell Separation
  • Granulopoiesis
  • Immunoregulators
  • Inhibitors
  • Leukemia
  • Progenitor Cells

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA). / Broxmeyer, Hal; Ralph, Peter; Margolis, Valerie B.; Nakoinz, Ilona; Meyers, Paul; Kapoor, Neena; Moore, Malcolm A S.

In: Leukemia Research, Vol. 3, No. 4, 1979, p. 193-203.

Research output: Contribution to journalArticle

Broxmeyer, Hal ; Ralph, Peter ; Margolis, Valerie B. ; Nakoinz, Ilona ; Meyers, Paul ; Kapoor, Neena ; Moore, Malcolm A S. / Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA). In: Leukemia Research. 1979 ; Vol. 3, No. 4. pp. 193-203.
@article{cbf34077ef804226966b32378b0cd2ef,
title = "Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA)",
abstract = "Cells in the bone marrow and blood of patients with acute and chronic myeloid and lymphoid leukemia which produce leukemia inhibitory activity (LIA) specific for normal granulocyte-macrophage progenitor cells (CFU-c) have been characterized as belonging to the third population of lymphoid-like cells which are neither T nor B but which have Fe receptors. The cells are non-adherent, non-phagocytic, of low density (3), slowly sedimenting (2-6 mm/h) and present in the sheep red blood cell rosetting populations which are E-, EAC-, Ig-, EA+, and are Ia- as determined by a complement cytotoxicity test using rabbit anti-human Ia-like antibody. The LIA-producing cell has been further characterized by its response to certain agents with known immunoregulatory activity. Bacterial lipopolysaccharide, tuberculin purified protein derivative, Bacillus Calmette-Gu{\'e}rin, dextran sulphate and pokeweed mitogen suppressed the production of LIA. Total suppression of LIA production by LPS required the constant presence of this agent; but hydrocortisone and dexamethasone abrogated LPS suppression of LIA production. LIA could not be found in normal human adult bone marrow and blood cells or fetal bone marrow, spleen, or liver cells. Further evidence for the specificity of LIA action was obtained since LIA did not inhibit erythropoietin dependent human erythroid progenitor cell (BFU-e, CFU-e) proliferation.",
keywords = "Cell Separation, Granulopoiesis, Immunoregulators, Inhibitors, Leukemia, Progenitor Cells",
author = "Hal Broxmeyer and Peter Ralph and Margolis, {Valerie B.} and Ilona Nakoinz and Paul Meyers and Neena Kapoor and Moore, {Malcolm A S}",
year = "1979",
doi = "10.1016/0145-2126(79)90042-0",
language = "English (US)",
volume = "3",
pages = "193--203",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA)

AU - Broxmeyer, Hal

AU - Ralph, Peter

AU - Margolis, Valerie B.

AU - Nakoinz, Ilona

AU - Meyers, Paul

AU - Kapoor, Neena

AU - Moore, Malcolm A S

PY - 1979

Y1 - 1979

N2 - Cells in the bone marrow and blood of patients with acute and chronic myeloid and lymphoid leukemia which produce leukemia inhibitory activity (LIA) specific for normal granulocyte-macrophage progenitor cells (CFU-c) have been characterized as belonging to the third population of lymphoid-like cells which are neither T nor B but which have Fe receptors. The cells are non-adherent, non-phagocytic, of low density (3), slowly sedimenting (2-6 mm/h) and present in the sheep red blood cell rosetting populations which are E-, EAC-, Ig-, EA+, and are Ia- as determined by a complement cytotoxicity test using rabbit anti-human Ia-like antibody. The LIA-producing cell has been further characterized by its response to certain agents with known immunoregulatory activity. Bacterial lipopolysaccharide, tuberculin purified protein derivative, Bacillus Calmette-Guérin, dextran sulphate and pokeweed mitogen suppressed the production of LIA. Total suppression of LIA production by LPS required the constant presence of this agent; but hydrocortisone and dexamethasone abrogated LPS suppression of LIA production. LIA could not be found in normal human adult bone marrow and blood cells or fetal bone marrow, spleen, or liver cells. Further evidence for the specificity of LIA action was obtained since LIA did not inhibit erythropoietin dependent human erythroid progenitor cell (BFU-e, CFU-e) proliferation.

AB - Cells in the bone marrow and blood of patients with acute and chronic myeloid and lymphoid leukemia which produce leukemia inhibitory activity (LIA) specific for normal granulocyte-macrophage progenitor cells (CFU-c) have been characterized as belonging to the third population of lymphoid-like cells which are neither T nor B but which have Fe receptors. The cells are non-adherent, non-phagocytic, of low density (3), slowly sedimenting (2-6 mm/h) and present in the sheep red blood cell rosetting populations which are E-, EAC-, Ig-, EA+, and are Ia- as determined by a complement cytotoxicity test using rabbit anti-human Ia-like antibody. The LIA-producing cell has been further characterized by its response to certain agents with known immunoregulatory activity. Bacterial lipopolysaccharide, tuberculin purified protein derivative, Bacillus Calmette-Guérin, dextran sulphate and pokeweed mitogen suppressed the production of LIA. Total suppression of LIA production by LPS required the constant presence of this agent; but hydrocortisone and dexamethasone abrogated LPS suppression of LIA production. LIA could not be found in normal human adult bone marrow and blood cells or fetal bone marrow, spleen, or liver cells. Further evidence for the specificity of LIA action was obtained since LIA did not inhibit erythropoietin dependent human erythroid progenitor cell (BFU-e, CFU-e) proliferation.

KW - Cell Separation

KW - Granulopoiesis

KW - Immunoregulators

KW - Inhibitors

KW - Leukemia

KW - Progenitor Cells

UR - http://www.scopus.com/inward/record.url?scp=0018667260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018667260&partnerID=8YFLogxK

U2 - 10.1016/0145-2126(79)90042-0

DO - 10.1016/0145-2126(79)90042-0

M3 - Article

C2 - 533990

AN - SCOPUS:0018667260

VL - 3

SP - 193

EP - 203

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 4

ER -